Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Take-Two Interactive Software Inc. Stock Advances 8.3%, Outperforms Peers

Take-Two Interactive Software Inc. Stock Advances 8.3%, Outperforms Peers

Dow JonesDow Jones2026/11/10 21:33

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Take-Two Interactive Software Inc. rallied 8.3% to $224.64 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.4% to 7,520.93 and Dow Jones Industrial Average falling 0.3% to 52,231.89.

Take-Two Interactive Software Inc. closed 15.5% short of its 52-week high of $265.94, which the company reached on July 7th.

The stock outperformed some of its peers, as Hasbro Inc. rose 0.7% to $121.82, Playtika Holding Corp. rose 5.4% to $2.73, and Mattel Inc. rose 2.63% to $16.00.

Trading volume totaled 8.2 million, compared to the 50-day average of 2.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 10, 2026 16:33 ET (21:33 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Deutsche Bank believes that the continuously expanding chip trade surplus in Asia is becoming a supporting force for the US dollar, as related profits are increasingly being reinvested into the US stock market.

智通财经•2026/11/16 23:03
The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Roche's (RHHBY.US) new breast cancer drug Wilserdly approved by FDA: Analysts predict peak annual sales could reach up to $14.5 billion

Roche's (RHHBY.US) new oral breast cancer drug has been approved by U.S. regulators, paving the way for this medication, which the pharmaceutical company hopes will transform the treatment of the disease.

智通财经•2026/11/16 22:53

Soros Family Office Leads in Reducing Nvidia Holdings, Top Billionaires Cashed Out Quietly Before Jensen Huang's Departure

Several ultra-high-net-worth family offices collectively reduced their holdings in Nvidia during Q3, including the Soros Family Office, BlueCrest, and Abu Dhabi sovereign investment institutions. This move secured profits just before CEO Jensen Huang was dismissed by the board on November 12 due to an extramarital affair scandal. More than ten institutions participated in the reduction, although all retained some holdings, with the combined market value of their shares still exceeding $1 billion. Meanwhile, some institutions continued to increase their positions against the trend.

华尔街见闻•2026/11/16 22:41